HealthcareServices

Peripheral Artery Disease Market Forecast: How Big Will It Be by 2030?

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the peripheral artery disease market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Peripheral Artery Disease Market expected to reach by 2030?_x000D_

The market size for peripheral artery disease has shown significant expansion over the past few years. This market is projected to expand from $4.62 billion in 2025 to $4.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. Historically, this expansion has been driven by factors such as the high prevalence of peripheral artery disease, insufficient understanding of PAD risk factors, a dependency on conventional treatments, insufficient availability of interventional specialists, and disjointed patient care systems._x000D_

_x000D_

The peripheral artery disease market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $6.69 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This anticipated growth is driven by several factors, including progress in minimally invasive peripheral interventions, the increasing uptake of drug-eluting balloons and stents, the proliferation of hospitals and specialized vascular clinics, enhanced patient awareness coupled with early detection efforts, and the expanding application of combined treatment approaches such as lifestyle adjustments and pharmacotherapy. Key trends anticipated during this period encompass the expanded deployment of AI for early PAD diagnosis and risk assessment, a surge in the adoption of cloud-based patient monitoring platforms, an intensified emphasis on genomic-guided personalized PAD treatments, the growing incorporation of IoT devices for monitoring after interventions, and the increasing utilization of smart manufacturing processes in the production of PAD devices._x000D_

_x000D_

#Access Your Free Sample Report for In-Depth Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp_x000D_

_x000D_

What Drivers Are Driving Adoption Within The Peripheral Artery Disease Market?_x000D_

The increasing incidence of peripheral artery diseases is projected to stimulate the expansion of the peripheral artery disease market in the future. This condition, peripheral artery disease, involves the constriction or obstruction of arteries located outside the heart, commonly in the legs, leading to diminished blood flow and potential health issues. Treating peripheral artery disease aids in alleviating its symptoms, boosting mobility, and lowering the likelihood of serious complications, thereby improving patients’ overall health. For example, data from June 2023, provided by the American Heart Association, a US-based nonprofit organization, indicates that an estimated 7 to 12 million individuals in the United States and 200 million people globally suffer from this condition. Consequently, the growing prevalence of peripheral artery diseases is fueling the development of the peripheral artery disease market._x000D_

_x000D_

What Segments Are Included Within The Peripheral Artery Disease Market?_x000D_

The peripheral artery disease market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories_x000D_

2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents_x000D_

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administrations_x000D_

4) By End Users: Hospitals, Specialty Clinics, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons_x000D_

2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents_x000D_

3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters_x000D_

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters_x000D_

5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices_x000D_

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices_x000D_

7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits For Interventional Procedures, Support Devices_x000D_

_x000D_

How Are Emerging Trends Affecting The Progression Of The Peripheral Artery Disease Market?_x000D_

Leading companies within the peripheral artery disease (PAD) market are concentrating on creating advanced solutions, such as dissolvable drug-eluting scaffold systems, in response to the increasing need for safer, more lasting, and less intrusive treatment methods for arterial blockages below the knee. These absorbable scaffold technologies are designed to restore proper blood flow before progressively dissolving, offering a significant improvement over conventional permanent metallic stents. For example, in April 2024, Abbott Laboratories, a medical-device company based in the U.S., launched the Esprit BTK Everolimus Eluting Resorbable Scaffold System, which represents a pioneering dissolvable stent therapy specifically for below-the-knee PAD. This system releases everolimus, a medication that helps prevent the re-narrowing of vessels, while its entirely resorbable structure naturally breaks down over time, thereby removing the long-term risks linked with metal implants. It provides medical professionals with an advanced option beyond traditional angioplasty or permanent stenting, particularly benefiting patients suffering from extended lesions or critical limb ischemia. Through its combination of drug delivery and temporary structural assistance, the Esprit BTK System aims to foster better vessel healing, decrease complications, and broaden treatment possibilities for intricate PAD conditions._x000D_

_x000D_

Who Are The Prominent Global Companies Shaping The Peripheral Artery Disease Market Landscape?_x000D_

Major companies operating in the peripheral artery disease market are Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc._x000D_

_x000D_

#Access The Complete Report For Deeper Market Insights:#_x000D_

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report_x000D_

_x000D_

Which Geographic Areas Are Emerging As Strong Markets For The Peripheral Artery Disease Market?_x000D_

North America was the largest region in the peripheral artery disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request Your Customized Peripheral Artery Disease Market Research Report for Competitive Advantage:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp_x000D_

_x000D_

#Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2026, By The Business Research Company#_x000D_

_x000D_

Coronary Artery Disease Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report_x000D_

_x000D_

Peripheral Arterial Disease Market Report 2026_x000D_

https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report_x000D_

_x000D_